I-ON Digital Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that I-ON Digital Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $433.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $32.6K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $97.9K | Apr 11, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Apr 28, 2023 |
| FY2022 | Sep 30, 2022 | $0 | Apr 28, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $10.47M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $7.95M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $7.09M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $9.21M | Apr 16, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $433.0K | Apr 15, 2026 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.34M | Jun 8, 2018 |
| FY2017 | Dec 31, 2016 | $1.95M | Jun 8, 2018 |
| FY2016 | Dec 31, 2015 | $1.95M | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $2.03M | Apr 19, 2016 |
| FY2013 | Dec 31, 2013 | $0 | Feb 7, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $433.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $11.6K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $34.9K | Apr 11, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Apr 28, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $4.39M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $2.43M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.83M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $3.01M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $366.2K | Jun 8, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.88M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($1.91M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($805.1K) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($27.6K) | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $1.99M | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.62M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | ($712.4K) | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $81.8K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $19.1K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($1.13M) | Jun 8, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.77M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($1.28M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($705.5K) | Apr 11, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Apr 28, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.70M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | ($276.0K) | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | ($432.0K) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $586.7K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($932.1K) | Jun 8, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $1.50M | Apr 8, 2022 |
| FY2021 | Dec 31, 2020 | $999.2K | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $838.2K | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $329.4K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $670.7K | Apr 16, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($998.0K) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($1.06M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($498.8K) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($792.9K) | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $136.4K | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $2.60M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $134.4K | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $171.9K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.9K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($854.4K) | Jun 8, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $66.7K | Apr 8, 2022 |
| FY2021 | Dec 31, 2020 | $21.1K | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $196.7K | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $155.3K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $91.1K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $851.0K | Jun 8, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.31M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $18.42M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $18.55M | Apr 11, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Apr 28, 2023 |
| FY2022 | Dec 31, 2021 | $14.41M | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $13.16M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $9.79M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $9.87M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $10.20M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $1.94M | Jun 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.06M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $2.64M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $853.8K | Apr 11, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Apr 28, 2023 |
| FY2022 | Dec 31, 2021 | $3.52M | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $3.86M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $2.73M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $2.44M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.18M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $1.08M | Jun 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.26M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $15.78M | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | $17.69M | Apr 15, 2026 |
| FY2022 | Dec 31, 2022 | $0 | Apr 28, 2023 |
| FY2022 | Dec 31, 2021 | $9.96M | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $8.82M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $6.58M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $7.43M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $8.02M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $850.9K | Jun 8, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.29M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($5.41M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($3.50M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($2.69M) | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $7.68M | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.52M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $3.90M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $4.61M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $4.53M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($2.56M) | Jun 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $158.2K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $270.1K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $36.1K | Apr 11, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Apr 28, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | $4.52M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $1.34M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.71M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.44M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $118.0K | Jun 8, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | Apr 8, 2022 |
| FY2021 | Dec 31, 2020 | $206.8K | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | $388.6K | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $491.9K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $280.0K | Apr 16, 2019 |
| FY2016 | Dec 31, 2016 | $2.1K | Apr 17, 2017 |
| FY2016 | Dec 31, 2015 | $5.4K | Apr 17, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 11, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Apr 8, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 26, 2021 |
| FY2018 | Dec 31, 2018 | 0 | Apr 16, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Jun 8, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Apr 17, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 11, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Apr 8, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 26, 2021 |
| FY2018 | Dec 31, 2018 | 0 | Apr 16, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Apr 16, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 34.11M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 31.11M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 27.41M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 19.72M | Jun 6, 2024 |
| FY2023 | Sep 29, 2022 | 19.72M | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | 35.03M | Apr 28, 2023 |
| FY2021 | Dec 31, 2020 | 35.03M | Apr 8, 2022 |
| FY2020 | Dec 31, 2019 | 35.03M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | 35.03M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 26.00M | Apr 16, 2019 |